MWNA
DVAX

Marshall Wace North America’s Dynavax Technologies DVAX Stock Holding History

Marshall Wace North America’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200,909
Closed -$1.47M – 1251
2019
Q1 		$1.47M Buy
+200,909
New +$1.96M 0.01% 592
2017
Q4 		– Sell
-133,382
Closed -$2.93M – 1416
2017
Q3 		$2.93M Buy
+133,382
New +$2.11M 0.02% 699

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Marshall Wace North America's DVAX Position: Q2 2019 in Review

Marshall Wace North America sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 200,909 shares — an estimated $1.47M sold.

Marshall Wace North America first reported a position in DVAX in Q3 2017 and held it in 2 quarters. The position peaked at $2.93M in Q3 2017. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • Marshall Wace North America reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 200,909 Dynavax Technologies shares in Q2 2019, an estimated $1.47M.
  • Marshall Wace North America first reported a position in Dynavax Technologies in Q3 2017 and held it in 2 quarters.
  • Marshall Wace North America's Dynavax Technologies position peaked at $2.93M in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.